Prostaglandin E1 plus methylcobalamin combination therapy versus prostaglandin E1 monotherapy for patients with diabetic peripheral neuropathy: A meta-analysis of randomized controlled trials

BACKGROUND: Prostaglandin E1 (P) or methylcobalamin (M) treatment has been suggested as a therapeutic approach for diabetic peripheral neuropathy (DPN) in many clinical trial reports. However, the combined effects of 2 drugs still remain dubious. OBJECTIVE: The aim of this report was to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, De-Qi, Zhao, Shi-Hua, Li, Ming-Xing, Jiang, Li-Lin, Wang, Yong, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221723/
https://www.ncbi.nlm.nih.gov/pubmed/30383660
http://dx.doi.org/10.1097/MD.0000000000013020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221723/
https://www.ncbi.nlm.nih.gov/pubmed/30383660
http://dx.doi.org/10.1097/MD.0000000000013020

Ejemplares similares